ORG Wealth Partners
GLUE icon

ORG Wealth Partners’s Monte Rosa Therapeutics GLUE Stock Holding History

ORG Wealth Partners’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$119 Buy
+10
New +$171 ﹤0.01% 2432

Other funds holding GLUE

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

ORG Wealth Partners's GLUE Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Monte Rosa Therapeutics (GLUE) in Q3 2026: 10 shares worth $119. The stake represents ﹤0.01% of the portfolio and ranks #2432 among its holdings.

73 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.

  • ORG Wealth Partners held 10 shares of Monte Rosa Therapeutics worth $119 as of Q3 2026.
  • Monte Rosa Therapeutics was a new ORG Wealth Partners position in Q3 2026.
  • Monte Rosa Therapeutics made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2432 holding.
  • 73 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.